Close

Mirati Therapeutics (MRTX), Verastem Oncology (VSTM) Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant NSCLC Nov 22, 2021 07:33AM
Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer Nov 22, 2021 07:30AM
Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer Nov 22, 2021 07:30AM
Pre-Open Movers 07/26: (SMSI) (TYPE) (GOOGL) Higher; (CARB) (MMSI) (MHK) (more...) Jul 26, 2019 09:27AM
Cancer Research UK, MSD and Verastem Collaborate to Trial New Combination of Immunotherapy Drugs Sep 30, 2016 05:00AM


Mar 3, 2016 07:15AM Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Mar 3, 2016 07:07AM Pfizer (PFE), Merck KGaA, Verastem (VSTM) Collaborate to Evaluate Avelumab + VS-6063 Combo in Ovarian Cancer
Mar 3, 2016 07:00AM Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Aug 26, 2015 01:04PM Unusual 11 Mid-Day Movers 8/26: (CAM) (ABGB) (FORD) Higher; (VSTM) ((RJET) (SKYS) Lower
Jul 9, 2014 10:00AM Verastem, Inc. (NASDAQ: VSTM) to Ring The NASDAQ Stock Market Closing Bell